Profound Medical Corp. (NASDAQ: PROF) announced preliminary unaudited financial results for the three months ended September 30, 2026. The company expects to report record-breaking quarterly revenue, with total revenue projected to fall between $9.8 million and $10.0 million.
According to the filing, this revenue range represents a significant increase compared to the prior year. The figures are expected to be approximately 85% to 89% higher than the $5.3 million reported in the third quarter of 2025. Sequentially, revenue is anticipated to grow approximately 292% to 300% compared to the second quarter of 2026, which was $2.5 million.
The company noted that its expected revenue is approximately 45% to 47% above the Bloomberg mean analyst consensus estimate of $6.78 million for the period. Additionally, the company expects its gross margin for the third quarter to exceed 70%.
Profound Medical intends to report its full third quarter 2026 financial results after the market close on Thursday, November 5, 2026. The company will host a conference call at 4:30 p.m. ET on that date to review the results and discuss business developments.
